Greenwich LifeSciences, Inc.
Nasdaq GLSI · Stafford, TX
Works in Dermatology · Oncology
Greenwich LifeSciences, Inc. is a clinical trial sponsor based in Stafford, TX, listed as Nasdaq GLSI. It has 1 active clinical trial with 2,250 planned participants, in Dermatology and Oncology.
Trial track record · since 2021
Financials · Nasdaq GLSI
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Greenwich LifeSciences, Inc
Greenwich LifeSciences, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 2,250 planned participants, in Dermatology, Oncology. Since 2021 it has completed 0 trials and stopped 0 early.
Greenwich LifeSciences, Inc is based in Stafford, TX and is listed as Nasdaq GLSI. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Greenwich LifeSciences, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-06.
Approve Suite is not affiliated with Greenwich LifeSciences, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.